Purpose of this study was to molecularly characterize a family in which two brothers (46 and 36 years) presented with a combination of retinitis pigmentosa (RP) and severe sensorineural hearing loss while father and sister (71 and 41 years) presented with isolated RP. Retinal phenotype was compared with phenotype of 17 patients with Usher syndrome type 1. Ophthalmological examination included assessment of Snellen visual acuity, color vision with Ishihara tables, Goldmann perimetry (targets II/1-4) and microperimetry. Fundus autofluorescence imaging and optical coherence tomography were performed. Direct sequencing of all coding exons and flanking intronic sequences of GJB2 (gap junction protein, beta 2) and PRPH2 (peripherin 2) genes was performed in younger brother. Other family members were analyzed with sequencing (GJB2), high resolution melt analysis (GJB2) or restriction enzymes (PRPH2). Brothers with hearing loss were found to carry a homozygous c.35delG mutation in GJB2, the most common mutation associated with recessive hearing loss. All patients were found to carry a novel heterozygous mutation c.389T > C (p.Leu130Pro) on PRPH2. Age of onset was higher in PRPH2 than USH1 patients, however with some overlap. Differentiation from retinal phenotype of USH1 could only be made in the oldest patient, who retained good central visual function after more than three decades of disease.
Introduction
Hereditary retinal disorders are an important cause of severe visual impairment. Many of these patients have associated handicaps, and it has been estimated that 10-30% of patients with retinitis pigmentosa (RP) also have some form of hearing impairment (Bayazit & Yilmaz, 2006; Keats, 2002) . Usher syndrome is a recessive disorder, characterized by RP and sensorineural hearing loss, which accounts for more than 50% of all deaf-blind patients (Vernon, 1969) or about 18% of pigmentary retinopathies (Boughman, Vernon, & Shaver, 1983) . Hearing loss can be severe (USH1), moderate (USH2) or progressive (USH3). Nonsyndromic autosomal recessive hearing loss is most commonly associated with mutations in GJB2, encoding connexin 26 (Duman & Tekin, 2012) . Nonsyndromic autosomal dominant retinitis pigmentosa (adRP) is most often caused by mutations in RHO, PRPF31, RP1, RDS or IMPDH1. Mutations in RDS/Peripherin (PRPH2) are responsible for 6% of ADRP (Daiger, 2004) . Purpose of this study was to molecularly characterize a family in which two brothers presented with a combination of RP and severe sensorineural hearing loss while father and sister presented with nonsyndromic RP.
Materials and methods

Patients
This case study included four related patients with RP and/or hearing loss. Two brothers (46 and 36 years) presented with a combination of RP and profound sensorineural hearing loss. Father and sister (71 and 41 years) presented with isolated RP. Diagnosis of RP was based on nyctalopia, visual field constriction, pigmentary retinal changes and full-field scotopic and photopic electroretinography. Profound sensorineural hearing loss was previously confirmed by audiometry (hearing threshold level in the better ear 0042-6989/$ -see front matter Ó 2012 Elsevier Ltd. All rights reserved. http://dx.doi.org/10.1016/j.visres.2012.07.011
Abbreviations: FAF, fundus autofluorescence; OCT, optical coherence tomography; ISe, inner segment ellipsoid (also known as IS/OS junction); ELM, external (outer) limiting membrane; RP, retinitis pigmentosa; USH, Usher; VA, visual acuity; ISH, Ishihara color vision test; ONL, outer nuclear layer; PRPH2, Peripherin 2 also known as RDS protein (retinal degeneration slow); GJB2, gap junction protein beta 2 also known as connexin-26 (Cx26).
at 81 dB or more, averaged over 0.5, 1, 2, 4 kHz; air and bone conduction thresholds showing the same degree of hearing loss). Retinal phenotype was compared with 17 USH1 patients, ages 7-69 years. They all had combination of recessive RP and hearing loss; 12 were genetically analyzed and confirmed as Usher syndrome. Study was approved by Slovenian Ethics Committee for Research in Medicine and all research procedures have been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. Informed consent was obtained from all subjects.
Ophthalmological examination
Ophthalmological examination included assessment of Snellen visual acuity, color vision with Ishihara tables, and Goldmann perimetry (targets II/1-4). Static microperimetry was performed with the Nidek MP1 (Nidek Technologies, Padua, Italy) after pupil dilation with topical 1% tropicamide. Fifty six stimuli in the central 20°of retina (program Humphrey10-216dB56s) were used. Stimuli were the size of Goldmann III target (4 mm 2 ), appeared for 200 ms and their intensities changed in 4-2 strategy. Fundus autofluorescence imaging of 30°field of view and 8-mm Spectral-domain OCT scan trough the fovea were performed simultaneously with a confocal scanning laser ophthalmoscope (OCT-SLO Spectralis, Heidelberg Retina Angiograph 2, Heidelberg Engineering, Dossenheim, Germany) after pupil dilation with topical 1% tropicamide. Temporal horizontal radius of the hyperautofluorescent ring (distance from fovea to inner border) was measured on FAF image using Spectralis software with micrometer caliper and rounded to 0.01 mm to compensate for measurement error. Conversion of 1 mm of retina to 3.5°of visual field was used.
Molecular methods
Mutational analysis of GJB2 and PRPH2 genes was performed in younger brother by direct sequencing of coding regions and flanking intronic sequences. ABI Prism 310 capillary sequencer (Applied Biosystems, Foster City, CA, USA) was used for sequencing in high resolution melt analysis (GJB2) and with restriction enzymes, where recognition site for AvaI was available (PRPH2). Results obtained with high resolution melt analysis were additionally confirmed by direct sequencing.
Retinitis pigmentosa
Results
Molecular results
Father and all three children were found to carry a heterozygous mutation c.389T > C (p.Leu130Pro) on PRPH2 gene (Fig. 1A) . Brothers with hearing loss were also found to carry a homozygous c.35delG mutation in GJB2 gene (Fig. 1B) . This mutation was found in heterozygous state in parents and was absent in sister.
Clinical data
Four patients presented with retinitis pigmentosa (Fig. 2) . Age of onset (nyctalopia) varied from 15-45 years (average 29 years). Patients presented with typical findings like bone spicules in the mid periphery, narrowed vessels, and optic disc pallor (not shown).
All patients had normal visual acuity and only father, who had the longest disease duration (41 years) had moderate loss of color vision (Ishihara 7/15 dex and 8/15 sin). Goldmann perimetry with II/4 target showed constricted visual fields in three patients (8-14°, disease duration 10-41 years; not shown) and relatively preserved visual field (60°) in the older brother, with 1 year of disease duration (Fig. 3A) . II/1 and II/2 were constricted in all four patients (3-9°and 5-12°, respectively; Fig 2B) . FAF revealed parafoveal hyperautofluorescent rings in all, with inner ring radii from 4°to 10° (Fig. 2) . Visual fields and rings were smaller in patients with longer disease duration (Fig. 3B.) . Inner ring border spatially correlated with inner segment ellipsoid (ISe) loss while outer ring border correlated with external limiting membrane (ELM) loss on OCT (Fig. 2) . Microperimetry showed loss of retinal sensitivity outside the rings (Fig. 2) .
Comparison of retinal phenotype between PRPH2 and USH1 patients
All patients had typical signs of RP, including of night vision loss and constricted visual fields. USH1 patients had in average earlier disease onset (nyctalopia) than PRPH2 patients (10 vs. 29 years, respectively, Fig. 4A ). Visual acuity was normal in all patients with PRPH2, even in patients with more than 30 years since onset, while USH1 retained good VA only to up to 30 years since onset (Fig. 4B ). All PRPH2 patients had relatively large (radius > 3°) hyperautofluorescent rings. Rings were seen in 8/11 (73%) of USH1 patients with up to 30 years of disease duration and in 1/6 (17%) patients with more than 30 years of disease duration. The latter ring was smaller than 3°. Other USH1 patients had central hyperautofluorescence (foveal patch) or atrophy, associated with photoreceptor degeneration in the foveal area. OCT in patients with rings showed similar morphological changes in the retina. From the fovea towards periphery, loss of ISe was seen, followed by ELM loss and significant thinning of outer nuclear (ONL) layer (Fig. 5) .
Discussion
Combination of RP and hearing loss in the two brothers was found to be a result of mutations in two different genes. Hearing loss was caused by homozygous mutation c.35delG in GJB2 gene, which is the most common mutation associated with hereditary hearing loss (Hochman et al., 2010) Retinitis pigmentosa was probably associated with a missense mutation c.389T > C (p.Leu130Pro) in PRPH2 gene. This novel mutation results in amino acid change in the large intradiscal loop D2 between the third and fourth transmembrane domains of the PRPH2 protein. The site is highly conserved and mutation is predicted as probably damaging by Polyphen.
Different retinal phenotypes have been associated with PRPH2 gene, depending on the site of mutation. AdRP was found to be associated with 34 different mutations, mostly located in the D2 loop (Boon et al., 2008) relatively early age at onset, between the 1st and 3rd decade, has been associated with Asp173Val, Asn244Lys and deletion of codon 118 or 119, while patients with other mutations usually have onset in the 3rd-5th decade. In most cases, a decrease in VA does not occur before 50 years of age (Boon et al., 2008) . Renner et al. published phenotype data of mother and daughter with p.Leu126Pro mutation, which is 4 amino acids upstream from our mutation. Mother (33 years) had normal VA on the right eye and 0.6 on the left eye while daughter (13 years) had normal VA. Both had normal color vision (Renner et al., 2009 ). All our patients had normal VA and only father (71 years, 41 years since onset) had moderately reduced color vision. Subjective disease onset varied from 15 PRPH2 patients had significantly later disease onset than USH1 patients however with some overlap. (B) Visual acuity in association with disease duration in PRPH2 and USH1 patients. PRPH2 patients retained normal VA late in the disease whereas significant decline was seen in USH1 patients after 30 years of disease duration.
to 45 years with average of 29 years, placing this family (mutation) in PRPH2 phenotypes described above. Two brothers in the studied family presented with concurrent severe hearing loss, thus mimicking the phenotype of USH1. We were interested if retinal phenotype could differentiate between PRPH2 and USH1 patients. We compared phenotype of the four PRPH2 patients with 17 USH1 patients. Twelve were so far genetically analyzed and thus confirmed. As they all presented with recessive RP and congenital profound sensorineural hearing loss it is very likely that most of them indeed have Usher syndrome. Milder disease was described in adRP (RHO) than recessive RP (USH2A) (Sandberg et al., 2008) . Results of our study agree with these findings. Average onset of nyctalopia was later in PRPH2 and disease progression was slower. Fundus autofluorescence and optical coherence tomography showed similar morphological changes. Hyperautofluorescent rings were seen in all PRPH2 patients and most USH1 patients in early stages while OCT showed loss of ISe and ELM with concurrent thinning of ONL from fovea towards periphery. Differentiation between retinal phenotypes of PRPH2 and USH1 patients could only be made in the oldest PRPH2 patient (father), who retained good central visual function after more than three decades of disease in contrast to USH1 patients that in late stages showed severe loss of central visual function accompanied with central FAF pattern of patch or atrophy.
This study shows that two concurrent diseases can mimic Usher syndrome. In our case, isolated RP in father and daughter helped with diagnosis. However in a case where parent's data was not known or RP was recessive or sporadic, we would not be able to differentiate the phenotypes in the younger patients. Such combination presents a rare but possible differential diagnosis of Usher syndrome.
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